Alzamend Neuro, Inc. (ALZN)
NASDAQ: ALZN · Real-Time Price · USD
1.820
-0.100 (-5.21%)
At close: Dec 31, 2025, 4:00 PM EST
1.850
+0.030 (1.65%)
After-hours: Dec 31, 2025, 7:40 PM EST
Alzamend Neuro Market Cap
Alzamend Neuro has a market cap or net worth of $6.92 million as of December 31, 2025. Its market cap has increased by 7.02% in one year.
Market Cap
6.92M
Enterprise Value
2.47M
1-Year Change
7.02%
Ranking
Category
Stock Price
$1.82
Market Cap Chart
Since the IPO on June 15, 2021, Alzamend Neuro's market cap has decreased from $1.15B to $6.92M, a decrease of -99.40%. That is a compound annual growth rate of -67.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 6.92M | 9.79% |
| Dec 31, 2024 | 6.30M | -0.56% |
| Dec 29, 2023 | 6.34M | -88.37% |
| Dec 30, 2022 | 54.47M | -67.73% |
| Dec 31, 2021 | 168.82M | -85.28% |
| Jun 15, 2021 | 1.15B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 965.87B |
| Johnson & Johnson | 500.07B |
| AbbVie | 407.98B |
| UnitedHealth Group | 297.97B |
| AstraZeneca | 287.56B |
| Novartis AG | 266.91B |
| Merck & Co. | 264.63B |
| Novo Nordisk | 229.27B |